Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy

Gynecological Endocrinology

Volumn 16, Issue 5, 2002, Pages 407-412

  Giusti, M ^a,b   Fazzuoli, L ^a   Cavallero, D ^a   Valenti, S ^a  

^a Department of Science ^*  (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Dopaminergic Therapy; Hyperprolactinemia; Nitric Oxide; Prolactin

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ESTRADIOL; NITRIC ACID; PROGESTERONE; PROLACTIN;

ADENOMA; ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG TOLERABILITY; EMPTY SELLA SYNDROME; ESTROGEN ACTIVITY; FEMALE; HUMAN; HYPERPROLACTINEMIA; LUTEAL PHASE; MENSTRUAL CYCLE; MICROADENOMA; PARKINSON DISEASE; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; STATISTICAL ANALYSIS;

EID: 0036813302     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/gye.16.5.407.412     Document Type: Article

References (21)

1. Shukovski L, Tsafriri T. The involvement of nitric oxide in the ovulatory process in the rat. Endocrinol 1995;40:2287-90
2. Yamauchi J, Miyazaki T, Iwasaki S, et al. Effects of nitric oxide on ovulation and ovarian steroido-genesis and prostaglandin production in the rabbit. Endocrinol 1997;138:3630-7
3. Imthurn B, Rosselli M, Jaeger AW, et al. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate. J Clin Endocrinol Metab 1997;82:388-94
4. Jilma B, Kastner J, Mensik C, et al. Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. Life Sci 1996;58:469-76
5. Morris NH, Sooranna SR, Steer PJ, Warren JB. The effect of the menstrual cycle on exhaled nitric oxide and urinary nitrate concentration. Eur J Clin Invest 1996;26:481-4
6. Russel KS, Haynes MP, Sinha D, et al. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracelluar signalling. Proc Natl Acad Sci USA 2000;97:5930-5
7. Hisamoto K, Ohmichi M, Kurachi H, et al. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 2001;276:3459-67
8. Shaarawy M, Nafei S, Abul-Nasr A, et al. Circulating nitric oxide levels in galactorrheic, hyperprolatinemic, amenorrheic women. Fertil Steril 1997;68:454-9
9. Fahy U, Hopton MI, Hartong M, et al. The lipoprotein profile of women with hyperprolactinaemic amenorrhea. Hum Reprod 1999;14:285-7
10. Scherr U, Sartori C. Defective nitric oxide synthesis: A link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. Eur J Endocrinol 2000;142:315-23
11. Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women. N Engl J Med 1993;329:247-56
12. Green LDC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite and (15N) nitrite in biological fluids. Analytical Biochem 1982;126:131-8
13. Valenti S, Cuttica CM, Fazzuoli L, et al. Biphasic effect of nitric oxide on testosterone and cyclic GMP production by purified rat Leydig cells cultured in vitro. Int J Androl 1999;22:336-41
14. Webster J, Piscitelli G, Polli A, et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinaemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med 1994;331:904-9
15. Guyda HJ, Friesen HG. Serum prolactin levels in humans from birth to adult life. Pediatric Res 1973;7:34-40
16. Maslar LA, Riddick DH. (1979). Prolactin production by human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 135:751-4
17. Khashihara K, Sakai K, Marui K, Shohmori T. L-DOPA does not facilitate nitric oxide production in the rat striatum and substantia nigra: In vivo microdialysis study. Life Sci 1998;63:59-64
18. Renodon A, Boucher JL, Sari MA, et al. Bromocriptine is a strong inhibitor of brain nitric oxide synthase: Possible consequences for the origin of its therapeutic effects. FEBS Lett 1997;406:33-6
19. Chwalisz K, Winterhager E, Thienel T, Garfield RE. Synergistic role of nitric oxide and progesterone during the establishment of pregnancy in the rat. Hum Reprod 1999;14:542-52
20. Biswas S, Kabir SN, Pal AK. The role of nitric oxide in the process of implantation in rats. J Reprod Fertil 1998;114:157-61
21. Fabregues F, Balash J, Manau D et al. Circulating levels of nitric oxide in successful and unsuccessful implantation after in vitro fertilization and embryo transfer. Relationship to estradiol and progesterone. Acta Obstet Gynecol Scand, 2000;79:564-9